Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995

Journal of the American College of Surgeons

Volumn 185, Issue 4, 1997, Pages 404-414

  Martins, Renato G ^a,b   Caplan, Robert H ^b   Rooney, Brenda ^b   Kisken, William A ^b  

^a Pamela J Lambert   (United States)

^b GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645917687     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(01)00946-2     Document Type: Article

References (36)

1. Gagel RF, Goepfert H, and Calleweler DL. Changing concepts in the pathogenesis and management of thyroid cancer. CA Cancer J Clin 1996;46:261–283.
2. American Association of Clinical Endocrinologists. Clinical practice guidelines for the management of thyroid carcinoma. Endocr Pract 1997;3:60–71.
3. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 1996;156:2165–2172.
4. Solomon BL, Wartofsky L, and Burman KD. Current trends in the management of well-differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 1996;81:333–339.
5. Ain KB, Papillary thyroid carcinoma. Etiology, assessment, and therapy. Endocrinol Metab Clin North Am 1995;24:711–760.
6. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19:545–576.
7. Grebe SKG, and Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995;24:761–801.
8. Azadiam A, Rosen IB, Walfish P, and Asa SL. Management considerations in Hürthle cell carcinoma. Surgery 1995;118: 711–715.
9. Grant CS. Operative and postoperative management of the patient with follicular and Hürthle cell carcinoma. Do they differ? Surg Clin North Am 1995;75:395–403.
10. Burman KD, Ringle MD, and Wartofsky L. Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am 1996; 25:49–68.
11. Cady B, and Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104: 947–953.
12. Caplan RH, Strutt PJ. Kisken WA, and Wester SM. Fine needle aspiration biopsy of thyroid nodules. Wis Med J 1991; 90:285–288.
13. American Association of Clinical Endocrinologists. Clinical practice guidelines for the diagnosis and management of thyroid nodules. Endocr Pract 1996;2:78–84.
14. McDonald M, Chan HS, Ross R, et al. Hürthle cell carcinoma: prognostic factors and results of surgical treatment (abstract). American Association of Endocrine Surgeons Annual Meeting. Surgery 1996;120:1000–1004, discussion 1004–1005.
15. Mazzaferri EL. Undifferentiated thyroid carcinoma and unusual thyroid malignancies. In: Mazzaferri EL, and Samaan NA, eds. Endocrine Tumors. Boston: Blackwell Scientific Publications; 1993:378.
16. McClellan DR, and Francis GL. Thyroid cancer in children. pregnant women, and patients with Graves’ disease. Endocrinol Metab Clin North Am 1996;25:27–48.
17. Mazzaferri EL, and Jhiang SM. Long-term impact of initial surgical and medical therapy of papillary and follicular thyroid cancer. Am J Med 1994;97:418–428.
18. Caplan RH, Abellera RM, and Kisken WA. Hü rthle cell neoplasms of the thyroid gland: reassessment of functional capacity. Thyroid 1994;4:243–248.
19. Pasieka JL, and Rotstein LE. Concensus conference on well-differentiated thyroid cancer: a summary. Can J Surg 1993; 36:298–301.
20. Arad E, O’Mara RE, and Wilson GA. Ablation of remaining functioning thyroid lobe with radioiodine after hemithyroidectomy for carcinoma. Clin Nucl Med 1993;18:662–663.
21. Briesley JD, and Tsang RW. External radiation therapy in the treatment of thyroid malignancy. Endocrinol Metab Clin North Am 1996;25:141–157.
22. Foster RS. Morbidity and mortality after thyroidectomy. Surg Gynecol Obstet 1978;146:423–429.
23. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 1986;61:978–996.
24. DeGroot LJ, Kaplan EL, McCormick M, and Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414–424.
25. Mazzaferri EL. Impact of initial tumor features and treatment selected in the long-term course of differentiated thyroid cancer. Thyroid Today 1995;18:1–2.
26. 131therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992;33:1132–1136.
27. 131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 1991;32:252–254.
28. Burman KD. How serious are the risks of thyroid hormone over replacement? Thyroid Today 1995;18:1–9.
29. Gulgeroff AJ, and Hershman JM. Medical therapy for differentiated thyroid carcinoma. Endocr Rev 1994;15:500–515.
30. Spencer CA, and Wand CC. Thyroglobulin measurements: techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 1995;24:841–864.
31. Galloway RJ, and Smallridge RC. Imaging in thyroid cancer. Endocrinol Metab Clin North Am 1996;25:93–113.
32. Mazzaferri EL. Treating high thyroglobulin with radioiodine—a magic bullet or a shot in the dark? J Clin Endocrinol Metab 1995;80:1485–1487.
33. Sherman SI, Tielens ET, Sostie S, et al. Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid cancer. J Clin Endocrinol Metab 1994;78: 629–634.
34. Brierley JD, and Tsang RW. External radiation therapy in the treatment of thyroid malignancy. Endocrinol Metab Clin North Am 1996;25:141–157.
35. Reeve TS, Curtin A, Fingleton L, et al. Can total thyroidectomy be performed as safely by general surgeons in provincial centers as by surgeons in specialized surgical units? Making the case for surgical training. Arch Surg 1994;129:834–836.
36. Harris SG. Thyroid and parathyroid surgical complications. Am J Surg 1992;163:476–478.